Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, RO 23-9424 and RP 67829

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue 2, 1993, Pages 273-280

  Spangler, S K ^a   Jacobs, M R ^b   Pankuch, G A ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DEACETYLCEFOTAXIME; FLEROXACIN; FLEROXACIN DEACETYLCEFOTAXIME ESTER; GREPAFLOXACIN; NAPHTHYRIDINE DERIVATIVE; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RO 40 6890; RP 67829; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; ANTI-INFECTIVE AGENTS, QUINOLONE; CEFOTAXIME; CEPHALOSPORINS; COMPARATIVE STUDY; CULTURE MEDIA; FLEROXACIN; HUMAN; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SUPPORT, NON-U.S. GOV'T;

EID: 0027417748     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/31.2.273     Document Type: Article

References (34)

1. Angehm, P., Hohl, P., Hubschwerlen, C. Then, R.1992. Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester Ro 41-3399. Antimicrobial Agents and Chemotherapy, 36, 2825-34.
2. Appelbaum, P. C.1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
3. Appelbaum, P. C, Spangler, S. K., Crotty, E. Jacobs, M. R.1989. Suspectibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones. Journal of Antimicrobial Chemotherapy 23, 509-16.
4. Berthaud, N., Duvoux, F., Rousseau-Blanchery, J. Desnottes, J. F.1991a. In vitro antibacterial activity of a new benzonaphthyridone antibiotic, RP 67829. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 370, p. 160. American Society for Microbiology, Washington, DC.
5. Berthaud, N., Huet, Y., Bussiere, J. C., Sautede, M., Selingue, M. Desnottes, J. F.19916. RP 67829, a new benzonaphthyridine antibacterial agent: in vivo efficacy for treating experimental staphylococcal and streptococcal infections in mice. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 372, p. 161. American Society for Microbiology, Washington, DC
6. Beskid, G., Fallat, V., Lipschitz, E. R., McGarry, D. H., Cleeland, R., Chan, K. et al.1989. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Antimicrobial Agents and Chemotherapy 33, 1072-7.
7. Borin, M. T., Hughes, G. S., Spillers, C. R. Patel, R. K.1990. Pharmacokinetics ofcefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil. Antimicrobial Agents anti Chemotherapy 34, 1094-9.
8. Chartrand, S. A., Pollack, J. R. Cavalieri, S. J.1991. In vitro activity of cefdinirCI-983, FK 482 versus pediatric bacterial pathogens. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1526, p. 353. American Society for Microbiology, Washington, DC.
9. Chin, N.-X. Neu, H. C.1988. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Antimicrobial Agents and Chemotherapy 32, 671-7.
10. Chin, N.-X. Neu, H. C.1991. Serum bactericidal activity of cefdinir, a new orally absorbed cephalosporin. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1525, p. 353. American Society for Microbiology, Washington, DC.
11. Christenson, J. G., Chan, K. K., Cleeland, R, Dix-Holzknecht, B., Farrish, H. H., Patel, I. 1990Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals. Antimicrobial Agents and Chemotherapy 34, 1895-900.
12. Cohen, M. A., Roland, G. E., Huband, M. D. Yoder, S. L.1991. CefdinirCI-983, a new oral cephalosporin: in vitro evaluation against respiratory and urogenital tract pathogen species. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1532, p. 354. American Society for Microbiology, Washington, DC.
13. Fass, R. J. Helsel, V. L.1988. In vitro activity of U-76,252CS-807, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 32, 1082-5.
14. Fuchs, P. C., Barry, A. L. Jones, R. N.1986. Cefixime disk susceptibility test criteria. Journal of Clinical Microbiology 24, 647-9.
15. Gaja, M., Kitsukawa, K., Kusano, N., Irabu, Y., Shigeno, Y. Saito, A.1991. In vitro and in vivo activities of OPC-17116, a new oral quinolone against Legionella. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1473, p. 344. American Society for Microbiology, Washington, DC.
16. Guttendorf, R. J., Misiak, P. M., Koup, J. R., Sedman, A. J. Vassos, A.1991. Safety, tolerance, and pharmacokinetics of cefdinirCI-983, FK-482 after single and multiple doses. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 125, p. 415. American Society for Microbiology, Washington, DC.
17. Hara, K. Kaku, M, Koga, H. Kohno, S.1991. In vitro activity of OPC-17116 against Mycoplasma pneumoniae and its penetration into sputum and human polymorphonuclear leukocytes. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1469, p. 344. American Society for Microbiology, Washington, DC.
18. Imada, T., Miyazaki, S., Nishida, M., Yamaguchi, K. Goto, S.1992. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrobial Agents and Chemotherapy 36, 573-9.
19. Isaacs, D., Slack, M. P. E., Wilkinson, A. R. Westwood, A. W.1986. Successful treatment of pseudomonas ventriculitis with ciprofloxacin. Journal of Antimicrobial Chemotherapy 17, 535-8.
20. Jones, R. N. Barry, A. L.1988. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253AR-3746, the active metabolite of the new cephalosporin ester, U-76,252CS-807. Antimicrobial Agents and Chemotherapy 32, 443-9.
21. Jones, R. N., Barry, A. L. Thomsberry, C.1989. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime. Antimicrobial Agents and Chemotherapy 33, 944-50.
22. Jones, R. N., Erwin, M. E. Gooding, B. B.1992. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates. Antimicrobial Agents and Chemotherapy 30, 1022-3.
23. Kimura, M., Kishimoto, T., Hino, J., Niki, Y. Soejima, R.1991. In vitro and in vivo activities of OPC-17116 against Chlamydial species. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1474, p. 344. American Society for Microbiology, Washington, DC.
24. Koike, M., Nii, S., Morita, S., Akiyama, H. Odomi, M.1991. OPC-17116, a new quinolone: pharmacokinetics and metabolism in healthy volunteers. In Program and Abstracts of the Thirty-first Inter science Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1482, p. 346. American Society for Microbiology, Washington, DC.
25. Linares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F. et al.1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain1979-1990. Clinical Infectious Diseases 15, 99-105.
26. McClain, J. B., Rhoads, J. Krol, G.1988. Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges. Journal of Antimicrobial Chemotherapy 21, 808-9.National Committee for Clinical Laboratory Standards1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard M7-A2. NCCLS, Villanova, PA.
27. Neihart, R. E., Lee, V. W., Downs, N., Harms, J. Hinthorn, D. R.Liu, C.1987. Trospectomycin penetration into CSF and comparative effectiveness in experimental meningitis. In Program and Abstracts of the Twenty-seventh Interscience Conference on Antimicrobial Agents and ChemotherapyNew York, 1987. Abstract 270, p. 143. American Society for Microbiology, Washington, DC.
28. Neu, H. C., Fang, W„ Gu. J.-W.Chin, N.-X.1992. In vitro activity of OPC-17116. Antimicrobial Agents and Chemotherapy 36, 1310-5.
29. Pitlick, W., Hutson, A., Lohse, P., Malone, D. Cabana, J.1991. The pharmacokinetics of OPC-17116, a new quinolone antibiotic, following multiple doses. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991. Abstract 1484, p. 346. American Society for Microbiology, Washington, DC.
30. Rotschafer, J. C., Crossley, K. B., Lesar, T. S., Zaske, D. Miller, K.1982. Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique. Antimicrobial Agents and Chemotherapy 21, 170-2.
31. Spangler, S. K., Jacobs, M. R. Appxlbaum, P. C.1992. Susceptibilities of penicillin- susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin and ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 856-9.
32. Stone, J. W., Linong, G., Andrews, J. M. Wise, R.1989. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration. Journal of Antimicrobial Chemotherapy 23, 221-8.
33. Tweardy, D. J., Jacobs, M. R. Speck, W. T.1983. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. Journal of Antimicrobial Chemotherapy 12, 133-9.
34. Ward, J. I. Koomhof, H.1980. Antibiotic-resistant pneumococci. In Current Clinical Topics in Infectious DiseasesIRemington, J. S. Swartz, M. N., Eds, pp. 265-87. McGraw Hill, New York.